Literature DB >> 15815968

Cancer rehabilitation.

Andrea L Cheville1.   

Abstract

Cancer-related functional impairments and the associated economic burden are likely to increase in coming decades. A variety of factors contribute to the current availability of comprehensive rehabilitation services in only a few cancer centers. In general, cancer patients are highly distressed by the loss of independent mobility and self-care. The majority of patients are amenable to receiving rehabilitation services. Reports describing the integration of rehabilitation specialists into the delivery of cancer care strongly suggest that patients independence can be optimized through established techniques. The provision of humane and effective rehabilitation requires the formulation of dynamic and clinically appropriate goals. Many goals are common to most malignancies, eg, reducing the functional impact of aerobic deconditioning and chemotherapeutic neuropathy. Others are highly disease-specific, such as scapular stabilization following cranial nerve IX sacrifice. The expectations of patients and clinicians must evolve in response to the progression of disease. Restorative, supportive, preventative, and palliative goals should be re-evaluated at critical points along the disease course. A rubric for the development and implementation of rehabilitation goals at different cancer stages is described and illustrated with examples from breast and head and neck cancers.

Entities:  

Mesh:

Year:  2005        PMID: 15815968     DOI: 10.1053/j.seminoncol.2004.11.009

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  16 in total

1.  Oncology Rehabilitation Provision and Practice Patterns across Canada.

Authors:  Alyssa Canestraro; Anthony Nakhle; Malissa Stack; Kelly Strong; Ashley Wright; Marla Beauchamp; Katherine Berg; Dina Brooks
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

Review 2.  The role of physical rehabilitation in stem cell transplantation patients.

Authors:  Amir Steinberg; Arash Asher; Charlotte Bailey; Jack B Fu
Journal:  Support Care Cancer       Date:  2015-05-14       Impact factor: 3.603

3.  Occupational therapy use by older adults with cancer.

Authors:  Mackenzi Pergolotti; Malcolm P Cutchin; Morris Weinberger; Anne-Marie Meyer
Journal:  Am J Occup Ther       Date:  2014 Sep-Oct

4.  Use of injectable spasticity management agents in a cancer center.

Authors:  Jack Fu; Carolina Gutiérrez; Eduardo Bruera; Ying Guo; Shana Palla
Journal:  Support Care Cancer       Date:  2012-11-11       Impact factor: 3.603

5.  A Survey Regarding the Knowledge, Attitudes, and Beliefs of Graduates of Cancer Rehabilitation Fellowship Program.

Authors:  Rajesh R Yadav; An T Ngo-Huang; Jack B Fu; Amy Ng; Christian Custodio; Eduardo Bruera
Journal:  J Cancer Educ       Date:  2019-04       Impact factor: 2.037

6.  THE STATE OF CANCER REHABILITATION.

Authors:  Jack Fu
Journal:  J Palliat Care Med       Date:  2012-05-18

7.  A randomized controlled trial of outpatient CAncer REhabilitation for older adults: The CARE Program.

Authors:  Mackenzi Pergolotti; Allison M Deal; Grant R Williams; Ashley L Bryant; Bryce B Reeve; Hyman B Muss
Journal:  Contemp Clin Trials       Date:  2015-08-04       Impact factor: 2.226

8.  Activities, function, and health-related quality of life (HRQOL) of older adults with cancer.

Authors:  Mackenzi Pergolotti; Allison M Deal; Grant R Williams; Ashley L Bryant; Jeannette T Bensen; Hyman B Muss; Bryce B Reeve
Journal:  J Geriatr Oncol       Date:  2017-03-09       Impact factor: 3.599

9.  Inpatient rehabilitation performance of patients with paraneoplastic cerebellar degeneration.

Authors:  Jack B Fu; Vishwa S Raj; Arash Asher; Jay Lee; Ying Guo; Benedict S Konzen; Eduardo Bruera
Journal:  Arch Phys Med Rehabil       Date:  2014-07-19       Impact factor: 3.966

10.  Cancer rehabilitation: psychosocial rehabilitation needs after discharge from hospital?

Authors:  Thorbjørn H Mikkelsen; Jens Søndergaard; Anders Bonde Jensen; Frede Olesen
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.